Global
Allergy Diagnostics Market Segmentation, By Product
& Service (Consumables, Instruments, Services), By Test Type (In Vivo Tests,
{Skin Prick Test (SPT), Intradermal Test, Patch Test}, In Vitro Tests, {Allergen-specific
IgE Test, Total IgE Test, Component-resolved diagnostics (CRD), Basophil
Activation Test (BAT)}, By Allergen Type (Inhaled Allergens, Food Allergens, Drug
Allergens, Other Allergens), By End User (Diagnostic Laboratories, Hospital-Based
Laboratories and Clinics, Academic and Research Institutions, Other End Users)-
Industry Trends and Forecast to 2033
Global Allergy Diagnostics Market
size was valued at USD 5367.6 million in 2024 and
is expected to grow at a CAGR of 10.8% during the forecast period of 2025 to
2033.
Global Allergy Diagnostics Market Overview
The Global Allergy Diagnostics Market
prevalence of allergic conditions such as asthma, allergic rhinitis, and food
allergies creates substantial growth. Market expansion is driven by three main
factors, which include rising environmental pollution, lifestyle changes, and
greater awareness of allergy-related health issues. Healthcare professionals
use multiple diagnostic methods, including skin prick tests, specific IgE blood
tests, and patch tests, to determine the exact allergens causing reactions. The
combination of technological progress and better diagnostic precision, along
with the increasing need for individualized allergy management, encourages
wider use in medical and research applications. The global market growth
benefits from rising healthcare spending alongside improved access to
diagnostic services.
Global Allergy Diagnostics Market Scope
|
Factors |
Description |
|
Years Considered |
·
Historical Period: 2020-2023 ·
Base Year: 2024 ·
Forecast Period: 2025-2033 |
|
Segments |
·
By Product & Service: (Consumables,
Instruments, Services) ·
By Test Type: (In Vivo Tests, {Skin Prick Test
(SPT), Intradermal Test, Patch Test}, In Vitro Tests, {Allergen-specific IgE
Test, Total IgE Test, Component-resolved diagnostics (CRD), Basophil
Activation Test (BAT)}), ·
By Allergen Type (Inhaled Allergens, Food
Allergens, Drug Allergens, Other Allergens) ·
By End User: (Diagnostic Laboratories,
Hospital-Based Laboratories and Clinics, Academic and Research Institutions,
Other End Users) |
|
Countries Catered |
North America ·
United States ·
Canada ·
Mexico Europe ·
United Kingdom ·
Germany ·
France ·
Spain ·
Italy ·
Rest of Europe Asia Pacific ·
China ·
India ·
Japan ·
Australia ·
South Korea ·
Rest of Asia Pacific Latin America ·
Brazil ·
Argentina ·
Rest of Latin America Middle East
& Africa ·
Saudi Arabia ·
South Africa ·
Rest of MEA |
|
Key Companies |
·
Thermo Fisher Scientific, Inc. |
|
Market Trends |
·
Increasing demand for IVD tests for allergy
diagnosis ·
Growing healthcare expenditure of effective
allergy diagnostic & therapeutic products |
Global Allergy Diagnostics
Market Dynamics
The market for Global Needle-free
Injectors is witnessing high rate of technological change due to increasing
demand for efficient and painless drug delivery devices that are easily
administered by the patients. Increasing prevalence of chronic diseases such as
diabetes and osteoporosis has resulted in the need for self-administrable
devices and less invasive administration methods. These injectors have
substantial benefits such as low incidence of needle-stick injuries, improved
patient compliance and rapid absorption of drugs. Rapid jet injectors in
combination with spring-based systems have enhanced the precision and control
in drug delivery systems. Wide acceptance of these devices in immunization
programs and their pediatric uses will drive their demand globally. Higher
prices and lack of awareness in developing regions are major restraints in
these regions. Despite the challenges, R&D activities, regulatory approvals
and healthcare investments will drive the growth of the market in both developed
and developing economies.
Global Allergy Diagnostics
Market Segment Analysis
The Global Allergy Diagnostics
Market divides into multiple categories according to product & service
types, test methods, allergen classifications, and end user applications, which
demonstrate the market’s diverse diagnostic needs and applications. The market
segmentation by Product & Service divides into consumables, instruments,
and services. Allergen extracts, assay kits, and reagents represent the primary
products in this segment because of their frequent application in repeated
testing procedures. Immunoassay analysers and luminometers are essential tools
for performing in vitro tests because they deliver precise results and high
processing capacity. Diagnostic centres and labs have expanded their service
range, which now encompasses test results analysis and interpretation along
with consultation services. Test Type creates market divisions between in vivo
tests and in vitro tests. The Skin Prick Test (SPT), Intradermal Test, and
Patch Test qualify as in vivo tests that healthcare facilities use because they
provide quick results and remain cost-effective. The increasing popularity of
in vitro tests stems from their dependable performance and safe nature since
they eliminate direct allergen exposure while maintaining operational
efficiency. The primary in vitro tests are allergen-specific IgE test along
with total IgE test, component-resolved diagnostics (CRD) and Basophil
Activation Test (BAT) which enables cellular-level allergic sensitivity
assessment.
The global market divides
according to allergen type into inhaled allergens which include pollen and dust
mites as well as food allergens comprising nuts and dairy as well as seafood
and drug allergens such as penicillin besides other allergens like latex and
insect venom. Inhaled allergens represent a major portion of diagnostic cases
for asthma and rhinitis while food allergies show an upward trend especially
among children. Diagnostic laboratories, hospital-based laboratories and
clinics, academic and research institutions along with wellness centres and
other end users make up the market's served customer base. Diagnostic
laboratories achieve the highest volume of tests because of their ability to
process a large number of tests simultaneously and their access to
sophisticated testing technologies. Integrated healthcare delivery systems
provide benefits to hospital-based laboratories, whereas research institutions
push forward innovation via clinical studies and allergy research.
Global Allergy Diagnostics
Market Regional Analysis
Distinct regional growth patterns
in the Global Allergy Diagnostics Market stem from diverse healthcare systems
and varying levels of allergy prevalence and awareness about diagnostic
processes. North America leads the diagnostic market due to its high allergic
disease rates combined with robust healthcare systems and advanced diagnostic
technologies. Germany, France, and the UK drive strong performance in the
European allergy diagnostic market through supportive public health initiatives
and reimbursement policies. The Asia-Pacific region experiences rapid growth as
higher pollution levels join increased urbanization to boost allergy disorder
awareness in China, India, and Japan. Healthcare infrastructure investments,
together with rising personal incomes, improve access to diagnostic services.
Healthcare advancements coupled with growing awareness are leading to more
allergy testing requests throughout Latin America and the Middle East & and
Africa. Areas lacking diagnostic facilities and affordable services encounter
immediate market entry obstacles.
Global Allergy Diagnostics Market Key Players
·
Thermo Fisher Scientific, Inc.
·
HYCOR Biomedical
·
EUROIMMUN Medizinische Labordiagnostika AG
·
Omega Diagnostics Group PLC
·
Lincoln Diagnostics, Inc.
·
AESKU GROUP GmbH
·
DASIT Group SPA
·
R-Biopharm AG
·
bioMérieux
·
Siemens Healthcare GmbH
Recent Developments
In July 2024, AliveDx
received IVDR CE‑mark approval for its novel microarray immunoassay
designed to detect specific IgE responses to protein allergens, boosting
diagnostic precision in allergy component testing
In July 2024, Roche
acquired microfluidic diagnostics specialist LumiraDx to strengthen its
point-of-care testing capabilities, enhancing access to rapid allergy
diagnostics in primary care settings.
Research Methodology
At Foreclaro Global Research, our
research methodology is firmly rooted in a comprehensive and systematic
approach to market research. We leverage a blend of reliable public and
proprietary data sources, including industry reports, government publications,
company filings, trade journals, investor presentations, and credible online
databases. Our analysts critically evaluate and triangulate information to
ensure accuracy, consistency, and depth of insights. We follow a top-down and
bottom-up data modelling framework to estimate market sizes and forecasts,
supplemented by competitive benchmarking and trend analysis. Each research
output is tailored to client needs, backed by transparent data validation
practices, and continuously refined to reflect dynamic market conditions.
